Who has invested in Eko?

ARTIS Ventures, Highland Capital Partners, Questa Capital, NTTVC are named among the investors backing Eko.

Eko Funding: $161M Raised, Series D (2024)

Eko funding overview

Eko is a Healthtech company based in Oakland. Eko has raised $161M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in January 2024. The round record for Eko runs through 2024; nothing later has been disclosed. Investors on record include ARTIS Ventures, Highland Capital Partners, Questa Capital, NTTVC. 4 distinct backers are named across the disclosed rounds.

Eko at a glance

Total raised: $161M
Latest round: Series D
Latest round date: January 2024
Industry: Healthtech
Headquarters: Oakland
Notable investors: ARTIS Ventures, Highland Capital Partners, Questa Capital, NTTVC

Frequently asked about Eko funding

How much has Eko raised?: Eko has raised $161M in total disclosed funding across the rounds on record.
Who has invested in Eko?: ARTIS Ventures, Highland Capital Partners, Questa Capital, NTTVC are named among the investors backing Eko.
What was the latest Eko funding round?: The most recent disclosed round is a Series D, announced in January 2024.
Where is Eko based?: Eko is based in Oakland.
What sector does Eko operate in?: Eko is tracked under Healthtech from Oakland, with $161M in disclosed funding.
When did Eko last raise?: The last disclosed Eko round closed in January 2024 at Series D.

Eko totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in Oakland below to benchmark round size and investor mix.

Eko Funding: $161M Raised, Series D (2024)

Eko funding overview

Eko at a glance

Frequently asked about Eko funding

Companies related to Eko (40)

Browse related funding lists (5)